EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies

Ernesto Aitella iD, Gianluca Azzellino iD, Ciro Romano iD, Lia Ginaldi iD, Massimo De Martinis iD

International Journal of Molecular Sciences · 23.09.2025 · 26 (19) · 9268

DOI: 10.3390/ijms26199268 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.09.2025. Verfasst von Ernesto Aitella und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Osteoporosis, Immunosenescence. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosenescence refers to the set of immunoendocrinological alterations underlying the progressive decline in innate and adaptive immune function that occurs with aging. It is closely linked to the concept of inflammaging, a state of low-grade chronic systemic inflammation that contributes to age-related diseases. In the elderly, key features of diseases such as rheumatoid arthritis, particularly in its elderly onset form, and senile osteoporosis are characterized by a decline in sex hormones and the immunoregulatory IL-2; an increase in serum autoantibodies and pro-inflammatory mediators such as TNF-α, IL-6; and upregulation of bone-related factors RANKL, DKK1, and sclerostin, including the dysregulation of the IL-33/IL-31 axis. The aim of this review is to examine the key molecular pathways of immunosenescence in osteoimmunology, as well as the potential for therapeutic modulation of inflammaging through biologic and target synthetic disease-modifying antirheumatic drugs, denosumab and romosozumab, with particular attention to their management in elderly patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidOsteoporosisImmunosenescenceHumansInflammationAnimalsMolecular Targeted TherapyAgingAntirheumatic Agents

Stichwörter der Autor:innen

biological therapieselderlygerontorheumatologyimmunosenescenceinflammagingosteoimmunologyrheumatoid arthritissenile osteoporosis

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • Clinical Immunology Outpatient Clinic, Division of Internal Medicine, Department of Advanced Medical and Surgical Sciences, "Luigi Vanvitelli" University of Campania, 80131 Naples, Italy.

ORCID-Profile: Ernesto Aitella, Gianluca Azzellino, Ciro Romano, Lia Ginaldi, Massimo De Martinis

Zitieren

APA

Aitella, E., Azzellino, G., Romano, C., Ginaldi, L., & De Martinis, M. (2025). Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies. International Journal of Molecular Sciences, 26(19), 9268. https://doi.org/10.3390/ijms26199268

Vancouver

Aitella E, Azzellino G, Romano C, Ginaldi L, De Martinis M. Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies. International Journal of Molecular Sciences. 2025;26(19):9268. doi:10.3390/ijms26199268

BibTeX
@article{Aitella2025,
  author = {Aitella, Ernesto and Azzellino, Gianluca and Romano, Ciro and Ginaldi, Lia and De Martinis, Massimo},
  title = {Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9268},
  doi = {10.3390/ijms26199268}
}
Kostenlos starten →